A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 30, 2012

Primary Completion Date

March 27, 2014

Study Completion Date

March 27, 2014

Conditions
Metastatic Colorectal Cancer
Interventions
BIOLOGICAL

Mycobacterium obuense

IMM-101 is a suspension of heat-killed whole cell M. obuense in borate-buffered saline.

RADIATION

SBRT

The CyberKnife system is normally used for the treatment of cancerous tumours in cases where the type and position of the tumour and the condition of the patient indicate that treatment may be curative. In this study, the CyberKnife is being used in an experimental way to deliver a targeted dose of stereotactic body radiation with extreme accuracy in order to damage a single tumour growth (metastasis) in the liver.

Trial Locations (2)

W1G 6AD

HCA International, The Sarah Cannon Research Institute, London

Unknown

The London Clinic, London

Sponsors
All Listed Sponsors
lead

Immodulon Therapeutics Ltd

INDUSTRY

NCT01539824 - A Study of IMM-101 in Combination With Radiation Induced Tumour Necrosis in Colorectal Cancer | Biotech Hunter | Biotech Hunter